CD5 (protein)

From Wikipedia, the free encyclopedia
Jump to: navigation, search
CD5
Protein CD5 (PBB).jpg
Available structures
PDB Ortholog search: PDBe RCSB
Identifiers
Aliases CD5, LEU1, T1, CD5 molecule
External IDs OMIM: 153340 MGI: 88340 HomoloGene: 7260 GeneCards: CD5
Gene location (Human)
Chromosome 11 (human)
Chr. Chromosome 11 (human)[1]
Chromosome 11 (human)
Genomic location for CD5
Genomic location for CD5
Band 11q12.2 Start 61,102,395 bp[1]
End 61,127,852 bp[1]
RNA expression pattern
PBB GE CD5 206485 at fs.png
More reference expression data
Orthologs
Species Human Mouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_014207
NM_001346456

NM_007650

RefSeq (protein)

NP_001333385
NP_055022

NP_031676

Location (UCSC) Chr 11: 61.1 – 61.13 Mb Chr 11: 10.72 – 10.74 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

CD5[5] is a cluster of differentiation expressed on the surface of T cells (various species) and in a subset of murine B cells known as B-1a. The expression of this receptor in human B cells has been a controversial topic and up to date there is no consensus regarding the role of this receptor as a marker of human B cells. B-1 cells have limited diversity of their B-cell receptor due to their lack of the enzyme terminal deoxynucleotidyl transferase (TdT) and are potentially self-reactive. CD5 serves to mitigate activating signals from the BCR so that the B-1 cells can only be activated by very strong stimuli (such as bacterial proteins) and not by normal tissue proteins. CD5 was used as a T-cell marker until monoclonal antibodies against CD3 were developed.

In humans, the gene is located on the long arm of chromosome 11. There is no confirmed ligand for CD5 but there is evidence that CD72, a C-type lectin, may be a ligand or that CD5 may be homophilic, binding CD5 on the surface of other cells.[6] CD5 includes a scavenger receptor cysteine-rich protein domain.

T cells express higher levels of CD5 than B cells. CD5 is upregulated on T cells upon strong activation. In the thymus, there is a correlation with CD5 expression and strength of the interaction of the T cell towards self-peptides.

Immunohistochemistry[edit]

CD5 is a good immunohistochemical marker for T-cells, although not as sensitive as CD3. About 76% of T-cell neoplasms are reported to express CD5, and it is also found in chronic lymphocytic leukemia and mantle cell lymphoma (both being B cell malignancies). It is commonly lost in cutaneous T-cell lymphoma, and its absence can be used as an indicator of malignancy in this condition. The absence of CD5 in T cell acute lymphoblastic leukemia, while relatively rare, is associated with a poor prognosis.[7]

References[edit]

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000110448 - Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000024669 - Ensembl, May 2017
  3. ^ "Human PubMed Reference:". 
  4. ^ "Mouse PubMed Reference:". 
  5. ^ "Entrez Gene: CD5 CD5 molecule". 
  6. ^ Brown MH, Lacey E (Nov 15, 2010). "A ligand for CD5 is CD5". Journal of Immunology. 185: 6068–74. PMC 2996635Freely accessible. PMID 20952682. doi:10.4049/jimmunol.0903823. 
  7. ^ Leong, Anthony S-Y; Cooper, Kumarason; Leong, F Joel W-M (2003). Manual of Diagnostic Cytology (2 ed.). Greenwich Medical Media, Ltd. pp. 67–68. ISBN 1-84110-100-1. 

Further reading[edit]

External links[edit]